Müller, A., Dickmanns, A., Resch, C., Schäkel, K., Hailfinger, S., Dobbelstein, M., . . . Kramer, D. (2020). The CDK4/6-EZH2 pathway is a potential therapeutic target for psoriasis. The journal of clinical investigation, 130(11), . https://doi.org/10.1172/JCI134217
Chicago-Zitierstil (17. Ausg.)Müller, Anne, Antje Dickmanns, Claudia Resch, Knut Schäkel, Stephan Hailfinger, Matthias Dobbelstein, Klaus Schulze-Osthoff, und Daniela Kramer. "The CDK4/6-EZH2 Pathway Is a Potential Therapeutic Target for Psoriasis." The Journal of Clinical Investigation 130, no. 11 (2020). https://doi.org/10.1172/JCI134217.
MLA-Zitierstil (9. Ausg.)Müller, Anne, et al. "The CDK4/6-EZH2 Pathway Is a Potential Therapeutic Target for Psoriasis." The Journal of Clinical Investigation, vol. 130, no. 11, 2020, https://doi.org/10.1172/JCI134217.